DINUTUXIMAB

UNII:	7SQY4ZUD30
Formula:
Preferred Substance Name:	DINUTUXIMAB

1363687-32-4
APN311
APN-311
CH14.18
CH-14.18
CH14.18-UTC
CH-14.18-UTC
CH1418
CH-1418
CHIMERIC ANTI-DISIALOGANGLIOSIDE (GD2) MONOCLONAL ANTIBODY (CH14.18/CHO)
DINUTUXIMAB [INN]
DINUTUXIMAB [JAN]
DINUTUXIMAB [MI]
DINUTUXIMAB [PURPLE BOOK CDER]
DINUTUXIMAB [USAN]
DINUTUXIMAB [WHO-DD]
DINUTUXIMAB BETA
DINUTUXIMAB BETA [INN]
DINUTUXIMAB BETA [WHO-DD]
IMMUNOGLOBULIN G1, ANTI-(GANGLIOSIDE GD2) (HUMAN-MUS MUSCULUS MONOCLONAL CH14.18 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CH14.18 LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(GANGLIOSIDE GD2) (HUMAN-MUS MUSCULUS MONOCLONAL CH14.18/CHO HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CH14.18/CHO LIGHT CHAIN, DIMER
QARZIBA
UNITUXIN

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

DINUTUXIMAB

Synonyms and Mappings

Resources